Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment

scientific article published on 3 August 2017

Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4111/ICU.2017.58.5.353
P932PMC publication ID5577332
P698PubMed publication ID28868507

P2093author name stringAram Kim
Myung-Soo Choo
Jung Hyun Shin
Kyeong-Ok Hoe
P2860cites workMast cell activation and response to tolterodine in the rat urinary bladder in a chronic model of intravesical protamine sulfate and bacterial endotoxin-induced cystitis.Q51138408
Localization of M 2 and M 3 Muscarinic Receptors in Human Bladder Disorders and Their Clinical CorrelationsQ60731292
Overactive bladder and painful bladder syndrome: there need not be confusionQ81094368
Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trialQ87191589
Persistence and compliance with medication management in the treatment of overactive bladderQ26765014
Pretreatment features to influence effectiveness of intravesical hyaluronic Acid instillation in refractory interstitial cystitis/painful bladder syndromeQ34267531
Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendmentQ34459826
The mast cell in interstitial cystitis: role in pathophysiology and pathogenesisQ34623214
Using the International Continence Society's definition of painful bladder syndromeQ35103916
The M2 muscarinic receptor mediates in vitro bladder contractions from patients with neurogenic bladder dysfunctionQ35743183
Mesenchymal Stem Cell Therapy Alleviates Interstitial Cystitis by Activating Wnt Signaling PathwayQ35844565
O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain SyndromeQ35996597
Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptorsQ36784801
AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndromeQ37865879
Interstitial cystitis and the overlap with overactive bladder.Q38042335
The paracrine effects of mesenchymal stem cells stimulate the regeneration capacity of endogenous stem cells in the repair of a bladder-outlet-obstruction-induced overactive bladderQ39217697
The urodynamic characteristics and prognostic factors of patients with interstitial cystitis/bladder pain syndromeQ39365881
Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitisQ40396295
Alteration of Urothelial Inflammation, Apoptosis, and Junction Protein in Patients with Various Bladder Conditions and Storage Bladder Symptoms Suggest Common Pathway Involved in Underlying PathophysiologyQ40873104
Elimination of Hunner's Ulcers by Fulguration in Patients With Interstitial Cystitis: Is It Effective and Long Lasting?Q41931656
A 2-year follow-up of quality of life, pain, and psychosocial factors in patients with chronic prostatitis/chronic pelvic pain syndrome and their spousesQ48031584
P275copyright licenseCreative Commons Attribution-NonCommercial 4.0 InternationalQ34179348
P6216copyright statuscopyrightedQ50423863
P433issue5
P304page(s)353-358
P577publication date2017-08-03
P1433published inInvestigative and clinical urologyQ27727133
P1476titleEvaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment
P478volume58

Reverse relations

cites work (P2860)
Q64326482Is It Possible to Prevent Symptom Recurrence After Transurethral Resection for Hunner Lesion?
Q59795311Longitudinal intravital imaging of transplanted mesenchymal stem cells elucidates their functional integration and therapeutic potency in an animal model of interstitial cystitis/bladder pain syndrome
Q47547764The Therapeutic Effect of Human Embryonic Stem Cell-Derived Multipotent Mesenchymal Stem Cells on Chemical-Induced Cystitis in Rats
Q91918150Verification of mesenchymal stem cell injection therapy for interstitial cystitis in a rat model

Search more.